(2013). Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation. Canadian Agency for Drugs and Technologies in Health.
Chicago Style CitationAntithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation. Canadian Agency for Drugs and Technologies in Health, 2013.
MLA CitationAntithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation. Canadian Agency for Drugs and Technologies in Health, 2013.
Warning: These citations may not always be 100% accurate.